MedPath

Human Gut Microbiota and Prebiotic Response

Not Applicable
Completed
Conditions
Healthy Gut Microbiota
Registration Number
NCT03595306
Lead Sponsor
Duke University
Brief Summary

This study is designed to examine the shift in gut microbiota and their metabolism after consumption of a dietary supplement (prebiotic) by healthy participants. The investigators will provide participants with a panel of over the counter prebiotics and monitor their gut microbiome response in stool. All prebiotics will be commercially available, over-the-counter food, food additives, or dietary supplements, without any known market-use adverse effects beyond minimal discomfort.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  • Provide Stool Samples at no risk to yourself
Exclusion Criteria
  • No oral antibiotic treatments within previous 1 month
  • No known allergy to milk products or lactose intolerance
  • no known allergy to wheat or gluten intolerance
  • no history of irritable bowel syndrome
  • no history of inflammatory bowel disease
  • no history of type-2 diabetes
  • no history of chronic kidney disease or reduced kidney function
  • no current intestinal obstructions
  • no current untreated colorectal cancer
  • not currently pregnant or breastfeeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
change in levels of SCFAs in stool samplesBaseline and 6 weeks
Secondary Outcome Measures
NameTimeMethod
change in levels of cytokines in stool samplesBaseline and 6 weeks

Trial Locations

Locations (1)

Duke University

🇺🇸

Durham, North Carolina, United States

Duke University
🇺🇸Durham, North Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.